Compare ClearPoint Neuro Inc (CLPT) vs Tesla, Inc. (TSLA) Price & Performance

ClearPoint Neuro IncTrade

Tesla, Inc.Trade

Price performance (Past 24H)

Key statistics

ClearPoint Neuro Inc vs Tesla, Inc. — how do they compare? ClearPoint Neuro Inc trades at $14.86 (market cap $454.21M), while Tesla, Inc. trades at $334.44 (market cap $1.31T). The key difference: Tesla, Inc. is far larger — about 2884.1× ClearPoint Neuro Inc's market cap, and ClearPoint Neuro Inc is trading nearer its 52-week high, Tesla, Inc. nearer its low. Which is the better fit depends on your goals.

	CLPT	TSLA
Market Cap	$454.21M	$1.31T
Sector	Health	Consumer Cyclical
52-Week High	$29.60	$489.88
52-Week Low	$8.66	$298.16
Enterprise Value	$488.79M	$1.29T

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ClearPoint Neuro Inc

No Aura AI signal available yet.

Tesla, Inc.

Tesla (TSLA) trades at $330.87, up 0.7% on the day, with a bearish technical signal from moving averages and a mixed fundamental picture. The stock shows high valuation multiples (P/E 308.16, P/S 11.36) amid declining profitability, with net income margin falling to 3.67% in 2025 from 15.49% in 2023. Recent news highlights regulatory approval for self-driving software in Europe and a potential cheaper EV model, but Q2 2026 earnings missed expectations.

Outlook remains polarized: analyst consensus price target of $393.87 suggests 19% upside, but high valuation and margin compression pose risks. Key catalysts include autonomy advancements and energy/robotics growth, while competition and execution challenges weigh on sentiment. The stock's trajectory hinges on delivering AI-driven revenue streams beyond automotive.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CLPT

View details →

TSLA

ChatGPT predicts Tesla's flying Roadster prototype by 2026, with commercial launch possible in 2027.Finbold · 4 hours agoBullish Investor Ron Baron predicts SpaceX could reach a $40 trillion valuation in 15 years, echoing his successful Tesla bet.24/7 Wall Street · 5 hours agoBullish Tesla shares fall 26% YTD, seen overvalued at $333 amid weak margins and costly growth bets.24/7 Wall Street · 5 hours agoBearish View details →

About ClearPoint Neuro Inc

ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.

About Tesla, Inc.

Tesla Inc. designs, manufactures, and sells high-performance electric vehicles and electric vehicle powertrain components. The Company owns its sales and service network and sells electric power train components to other automobile manufacturers. Tesla serves customers worldwide.